DARATUMUMAB Pharmacologic Class Indexing
- Class set ID
- e5312ee6-4124-47ad-90a6-68f950f989d7
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use DARZALEX FASPRO safely and effectively. See full prescribing information for DARZALEX FASPRO. DARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) injection, for subcutaneous use Initial U.S. Approval: 2020 | Janssen Biotech, Inc. | Eurofins Lancaster Laboratories, Inc | Charles River Laboratories | Catalent Indiana, LLC | Biogen (Denmark) Manufacturing ApS | Jannsen Biologics B.V. | Cilag AG | Janssen Vaccines Corp. | Janssen Sciences Ireland UC | Bioreliance Corporation | 20260211 | 31 |
| These highlights do not include all the information needed to use DARZALEX safely and effectively. See full prescribing information for DARZALEX. DARZALEX ® (daratumumab) injection, for intravenous use Initial U.S. Approval: 2015 | Janssen Biotech, Inc. | AndersonBrecon Inc. | Biogen (Denmark) Manufacturing ApS | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) | Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Helmut-Vetter-Strasse) | Vetter Pharma Fertigung GmbH & Co. KG (Langenargen Eisenbahnstrasse) | Jannsen Biologics B.V. | Cilag AG | Samsung Biologics Co., Ltd. | Baxter Pharmaceutical Solutions | Biogen MA, Inc. | PPD Development Ireland Ltd. | Janssen Sciences Ireland UC | Lonza AG | Eurofins Biolab Srl | 20251117 | 43 |